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Abstract 
Objective: To evaluate two saliva collection methods for DNA yield and quality as 
applied to a large, integrated, multi-centre, European project involving the collection of 
biological material from children. Design: Cross-sectional multi-centre comparative 
study in young children. Methods: Saliva samples were collected from 14,019 children 
aged 2-9 years from eight European countries participating in the IDEFICS 
(Identification and prevention of Dietary- and lifestyle-induced health EFfects In 
Children and infantS) study. This involved either the collection of 2 ml of saliva from 
children who were able to spit, or using a sponge to collect whole saliva and buccal 
mucosal cells from the inside of the mouth of younger children unable to spit. Samples 
were assembled centrally in each participating centre and subsequently dispatched for 
DNA extraction and biobanking to the University of Glasgow. A subgroup of 4,678 
samples (approximately 33% of sampled individuals) was chosen for DNA extraction 
prior to genotyping. Results: The whole saliva collection method resulted in higher DNA 
yield than the sponge collection method (mean ± SD; Saliva: 20.95 ± 2.35 µg,; Sponge: 
9.13 ± 2.25 µg; P<0.001). DNA quality as measured by A260/A280 was similar for the two 
collection methods. A minimum genotype calling success rate of 95% showed that both 
methods provide good quality DNA for genotyping using TaqMan® allelic 
discrimination assays. Conclusions: Our results showed higher DNA yield from the 
whole saliva collection method compared to the assisted sponge collection. However, 
both collection methods provided DNA of sufficient quantity and quality for large-scale 
genetic epidemiological studies. 
 
Keywords: saliva; sample collection; DNA extraction; DNA biobank
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Introduction 
Genetic epidemiology studies and clinical trials involving genetic association analysis are 
highly dependent on collecting, storing and distributing DNA of good quality from a 
representative sample of participants to examine genetic influences on treatment response 
and disease risk (1). Genotyping success rates depend on DNA quality and yield (2). The 
traditional method of collecting genetic material suitable for epidemiological studies and 
multiplex genotyping assays has been based on use of blood samples (3, 4), but this poses 
challenges, both financial and practical in large studies, particularly when children are 
investigated. Saliva is increasingly being collected in large studies because of its potential 
as diagnostic material (5) and has previously been shown to be a reliable source of human 
genomic DNA suitable for large genetic epidemiology studies (6). The non-invasive 
nature of this collection method makes it particularly suitable for children. Buccal swabs 
are convenient and relatively inexpensive compared to blood sampling (7). Saliva 
sampling has therefore become more popular (Table 1) as the methods for extraction of 
high quality DNA have developed and as costs have been reduced. 
 
Saliva-based methods typically yield DNA of sufficient quantity and quality to carry out 
extensive genotyping (see Table 1). It would also appear that these convenient and non-
invasive methods increase response rate considerably in epidemiologic studies. However, 
most previous studies using saliva-based methods have employed relatively small 
numbers of adult subjects and it therefore remains to be determined whether these 
methods are suitable for producing DNA of high quality and yield in larger studies, 
especially those involving young children. The IDEFICS (Identification and prevention 
of dietary- and lifestyle-induced health effects in children and infants) study is an 
integrated project funded by the 6th Framework Programme of the European 
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Commission and with a cohort size of 16,224 young children is one of the largest single 
studies to undertake saliva/DNA collection (8-13). Here we describe the design and 
methodological approaches used for DNA collection, extraction, biobanking and 
genotyping in the IDEFICS study based on the analysis of a subgroup of 4,678 samples 
selected from the full IDEFICS cohort. 
 
Methods 
Participants and saliva collection 
Participants in the IDEFICS study included children from eight European countries: 
Spain, Estonia, Germany, Cyprus, Italy, Denmark, Hungary and Sweden. All applicable 
institutional and governmental approvals were obtained and all regulations concerning 
the ethical use of human volunteers were strictly adhered to during this research. Initially 
31,543 children were contacted for the IDEFICS study, of whom 16,864 participated in 
the first assessment and 16,224 fulfilled the inclusion criteria (data available for age, 
gender, weight and height) (13). Of these 16,224 included subjects, 14,019 (86.4%) 
provided a saliva sample. The core characteristics of the included subjects from the 
various survey centers are presented in Table 2. Approximately 2 ml of saliva was 
collected from children who were able to provide a sputum sample (Oragene DNA Self 
Collection Kit, tube format OG-300; DNA Genotek Inc., Canada), while sponges 
(Oragene DNA Self Collection Kit, disc format OG-250 and CS-1 sponge accessory; 
DNA Genotek Inc., Canada) were used to soak up as much saliva as possible from the 
inside of the mouths of younger children unable to spit. Measurements in the IDEFICS 
study were undertaken by mobile field testing teams that visited the schools and nurseries 
of the children, or when children visited a testing centre. All samples were therefore 
collected under the supervision of trained personnel as subjects were typically too young 
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to follow the instructions of the manufacturer. Prior to sample collection, children were 
advised to rinse their mouths with drinking water and to wait at least 5 min before 
providing a saliva sample. When using the saliva collection tubes, children were advised 
to spit into the tube until saliva had been collected up to the level indicated on the 
collection container (approximately 2 ml). Sponge samples were collected by a trained 
individual and the sponges were cut into the collection disk container according to the 
instructions of the manufacturer. Once collected, the trained individual was responsible 
for covering the tube or disk by placing the cap securely and inverting the container 
repeatedly for approximately 10 sec to allow the saliva sample to mix well with the 
Oragene chemistry (DNA Genotek Inc., Canada). Samples from each country were stored 
at room temperature (approximately 10 to 15 weeks) and subsequently couriered to the 
central laboratory at the University of Glasgow (UGLW) for DNA extraction, biobanking 
and genotyping.  
 
DNA processing/purification/extraction 
Genomic DNA was extracted from a subgroup of 4,678 samples (all satisfied the 
following data availability selection criteria: parental questionnaire, height, weight, hip 
and waist circumferences, age, gender, birthplace and language spoken at home; see 
Table 2). Samples collected using the sponge method were available from 1,042 girls and 
1,178 boys. Samples collected as whole saliva were available from 1,015 girls and 1,086 
boys (357 samples were not recorded accurately regarding the saliva method, thus were 
excluded from the total number of 4,678. DNA from saliva collected in Oragene 
containers should be stable for at least five years at ambient temperature and resists 
degradation even when stored at temperatures as high as 50°C (17). Upon arrival at the 
central laboratory at UGLW, samples were logged using a barcode reader system and 
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stored at 4°C during processing. DNA was extracted using the protocol for manual 
purification of DNA from saliva advocated by the manufacturer (18) with minor 
adjustments to the protocol as detailed below. Prior to extraction, samples were incubated 
overnight at 50°C in an air incubator (Binder B28, BINDER GmbH, Tuttlingen, 
Germany). Following this, 500 µl of each sample was transferred into a 1.5 ml 
microcentrifuge tube and the remaining 1.5 ml sample was resealed in the original 
collection vessel and frozen at -20°C. Oragene DNA purifier (20 µl) was added to the 
microcentrifuge tube containing the sample, mixed by vortexing for a few seconds and 
then incubated on ice for 10 min. Following incubation, the sample mix was centrifuged 
using a microcentrifuge at room temperature for 10 min at 13000 rpm (15,000 × g). The 
supernatant was carefully transferred with a pipette into a fresh microcentrifuge tube, 500 
µl of 100% ethanol at room temperature was added and the tube mixed by inverting 
approximately 10 times. The tube was then allowed to stand at room temperature for 10 
min to precipitate the DNA followed by centrifugation at room temperature for 2 min at 
13000 rpm. The supernatant was removed and discarded. Pellets were dried in an air 
incubator at 50°C for about 20 min and taken up in 500 µl of TE buffer (100 mM Tris, 10 
mM EDTA, pH 8.0). Samples were vortexed momentarily and stored at room 
temperature overnight to encourage DNA dissolution. Extracted samples were then stored 
at -20°C until quantification. Samples were extracted in batches of 24 or 48, with each 
trained laboratory worker comfortably processing the extraction of 96 samples per day. 
 
DNA Quantification 
Aliquots (167 µl) of each of the 4,678 successfully extracted DNA samples were 
transferred to 2 ml deep well plates (Starlabs UK Ltd, Buckinghamshire, UK) and 
quantified using the Nanodrop Technologies Nanodrop® ND-8000 Spectrophotometer 
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(Wilmington, DE, USA) measuring 8 samples at a time using a multichannel pipette to 
transfer 1.5 µl undiluted sample to the sample platform. DNA concentrations were 
estimated from absorbance readings at 260nm (A260) using a 1 O.D. unit = 50 µg/ml 
conversion factor. A260/A280 ratios were also measured. Values for A260/A280 ratio 
normally average approx. 1.8, with intact, high purity DNA usually having a ratio 
between 1.6 and 2.0. Ratios below approximately 1.6 indicate protein contamination and 
potentially reduced DNA stability and quality for polymerase chain reaction (PCR) 
amplification. Values above approx. 2.0 can indicate other small molecule/ionic 
contamination of the DNA solution. After a first round of quantification, DNA was 
diluted to a working concentration of 10 ng/µl in TE buffer in 2 ml 96 deep well plates 
and subsequent aliquots dispensed into 1 ml deep well plates (Starlabs UK Ltd, 
Buckinghamshire, UK) before storing the original samples in 2 ml plates at -20°C. The 
working samples were held at 4°C for several weeks during the genotyping analysis.  
 
Genotyping  
Genotyping was performed in all 4,678 samples for eight single nucleotide 
polymorphisms (SNPs) from the β2-adrenergic receptor (ADRB2) gene (two assays) and 
from the angiotensin I converting enzyme 1 (ACE) gene (6 assays) using Taqman® assays 
(Applied Biosystems, Warrington, UK). No DNA template controls were included on 
each plate. Genotype calls were made by the analysis software (StepOneTM v2.1; Applied 
Biosystems, Warrington, UK). 
 
Statistical analysis 
Analyses were carried out using SPSS software package, version 15.0 (SPSS Inc., 
Chicago, USA) and MINITAB 15.1.30 (Minitab Ltd., Coventry, UK). Distributions of 
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DNA yield and A260/A280 ratio (by extraction method) were examined and normality 
assessed using the Anderson-Darling normality test. Non-normal distributions were 
transformed using the standard function (e.g. raw, log, inverse etc.) closest to optimal 
after Box-Cox analysis. Group differences for normally distributed (i.e. transformed) 
variables were tested using an independent t-test, with Welch’s correction where 
variances were unequal (evaluated using Levene’s test). For presentation purposes, mean 
values and other relevant statistics were back-transformed. Differences were considered 
statistically significant at P<0.05. Data are presented as mean ± SD/ or as median and 
interquartile range. 
 
 
Results 
DNA extraction yield and quality (by A260/A280 ratio) were evaluated in the full sample 
set and by extraction method. Some samples (1% of the 14,019 samples taken) were dry 
(indicating leakage of the saliva and chemicals present in the Oragene kit) upon receipt at 
the central laboratory at University of Glasgow (UGLW) and/or were not properly 
labeled. Of the 4,678 samples selected for DNA extraction, 100% were successfully 
extracted. Investigation of the distribution of DNA yields from the successful extractions 
revealed 14 samples with improbable high yields (>1000 µg), 42 samples with zero or 
negative yield (based on negative A260 readings) and 13 samples with zero or negative 
A260/A280 readings. These ‘low yield’ samples were excluded from further analysis. An 
upper yield cut-off for inclusion in the analysis was defined as 3 standard deviations (SD) 
from the mean. As a result, a further 94 samples were excluded, leaving a total of 4,584 
samples with acceptable yield for final analysis. Yield and quality data are given for these 
included samples in Table 3. In 357 of the 4,584 samples, saliva collection method was 
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not recorded accurately. Therefore, these samples were excluded solely from the analysis 
of differences between saliva collection methods. The whole saliva collection method 
resulted in higher DNA yield than the sponge collection method (mean ± SD; Saliva: 
20.95 ± 2.35 µg, Sponge: 9.13 ± 2.25 µg; P<0.001). DNA quality (as assessed by 
A260/A280 ratio) did not differ between the two collection methods. Analysis of the 
relationship between DNA yield and quality (Figure 1, n=4,070) revealed that high 
A260/A280 ratios were mainly observed in low yield samples prepared from sponges, while 
low ratios were predominantly observed in either high yield samples prepared from saliva 
or low yield samples prepared from sponges. Low yield samples from the sponge 
collection method appear to have a spread of A260/A280 ratios without a peak around 1.8 
suggesting that these samples were unlikely to be accurately measured and/or to be of 
useful quality. For the whole saliva collection method, on the other hand, low yield 
samples seemed to cluster around A260/A280 ratios of about 1.6-2.0, probably representing 
DNA of sufficient quality to be usable in genotyping experiments.  
 
PCR was performed on eight SNPs from the ADRB2 and ACE genes. The proportion of 
samples in which genotypes were successfully called (the genotype-calling success rate) 
was 96-97% (N=4,678) (Table 4). To analyse the genotyping success rate in relation to 
DNA quality, we applied cutoffs at A260/A280 ratios <1.5 and >2.1, and at DNA yields 
(expressed as natural log) of <0.5 or >5.0 (see Figure 1; these values were arbitrarily 
selected as being unusual in DNA of good quality made by the methods applied here, and 
as being the points that would create an ‘outlier’ dataset representing about 10% of the 
samples). In all, 427 samples fell outside the cutoffs and were used in further analysis as 
an ‘outlier’ dataset. Of these outliers, 83.1% were successfully genotyped in all 8 assays, 
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and 94.6% were successfully genotyped in at least 6 assays. The corresponding 
proportions for the non-outliers were 89.8% and 98.7%, respectively (see Table 5). 
 
Discussion  
These results demonstrate the effectiveness of the present methodological approaches 
used for DNA collection, extraction, biobanking and genotyping for use in large 
epidemiological studies in children such as those participating in the IDEFICS study. The 
overwhelming majority (4584 out of 4678 or 98%) of samples provided DNA of 
sufficiently high yield and quality (Table 3) for multiple genotyping assays as evidenced 
by the high genotyping success rates for both DNA collection methods (Table 4). The 
DNA yield differed between the two collection methods, with whole saliva yields being 
higher than yields from sponges (Table 3) and this is in line with previous reports in the 
literature (1,2,4,5,14-16,19-21). Total DNA yield from the 4 ml Oragene DNA/saliva 
solution fulfilled, on average, the specifications of the manufacturer of above 20 µg (22) 
for the whole saliva collection method (Table 3). However, considerable variability in 
DNA yield was evident from the data presented in Table 3, with a median and 
interquartile (IQ) range of 21.8 µg and 11.9-38.2 µg, respectively. In terms of the sponge 
saliva collection method, total DNA yield in the present study (Table 3) was somewhat 
lower (median 9.1 µg, IQ: 5.2-15.9 µg) than the specifications of the manufacturer 
(median 13.4 µg; 23) Again, considerable variability in DNA yield from the saliva 
sponge collection method was evident in the present study. Nevertheless, the genotyping 
success rate was high for both methods regardless of the lower yield when using the 
sponge method (Table 4) and in line with the success rate expected when using higher 
yield methods from blood and other biological material. The genotype-calling success 
rates (the average being 96-97% and the minimum, amongst the 8 SNPs tested being 
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95%) were well within expectations for the TaqMan assay approach to SNP genotyping. 
Genotyping failure can be due to many factors, including subtle variation in DNA quality 
that is not visible in the yield and ratio data, as well as factors operating during PCR 
setup. Interoperator variability may have contributed to the former. It should be noted 
that for the purposes of the present analysis we did not control for the effect of the age of 
the child on DNA yield. Whole saliva was generally obtained from children towards the 
higher end of the age range (typically ages 6-9 years) and it is likely that a larger amount 
of saliva was collected in these children (although instructions were to collect precisely 2 
ml saliva samples), or that there was a higher DNA concentration in the saliva samples 
obtained in these older children. DNA quality, however, was very similar for the two 
collection methods. Looking at the plot of DNA yield vs quality in Figure 1 it was clear 
that samples with unusually high A260/A280 ratios tended to have low yield and have been 
prepared from sponges, probably reflecting the low concentration of human cellular 
material and high levels of bacterial contamination in material collected on sponges. By 
contrast, low ratios were mainly observed in either high yield samples prepared from 
saliva or low yield samples prepared from sponges. Low ratios usually indicate protein 
contamination, which is often the case in low yield circumstances. Protein contamination 
in the high yield samples from saliva probably reflects high levels of bacterial 
contamination or possibly the presence of food particles in substantial quantities. Future 
analysis will address the question of whether yield is different per ml of saliva collected 
at different ages and whether genotype-calling success rate varies with collection method, 
DNA yield or A260/A280 ratio. Saliva collection as a method for collecting genetic 
material is particularly applicable for children in the general population and has been 
found to be associated with significantly higher participation rates compared to collection 
methods utilizing venous blood (24). Interestingly, non-invasive sample collection 
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methods (i.e. use of urine and saliva) showed higher response rates than samples 
collected by venous blood and capillary blood in the multicentre IDEFICS study (56.6% 
and 90.1% for venous blood and saliva, respectively) (24). The good response rate 
amongst subjects, and high DNA extraction and genotyping success rates make collection 
of saliva viable as a method for collecting samples for extraction of genomic DNA in 
large scale multicentre studies in young children.  
 
In summary, whole saliva and sponge collection methods provided DNA yields and 
quality sufficiently high for successful genotyping rates, making it suitable for large scale 
epidemiological studies. These results support the use of the Oragene Saliva collection 
kits in large scale studies of children. The fact that the present data comes from a large 
cohort of young children provides unique insight as no other study of this nature has been 
conducted in children to date.  
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Tables and Figure 
 
 
Figure 1. The relationship between DNA yield and quality from whole saliva and 
sponge samples. 
A260 measurements were used to calculate DNA yield (µg) then natural log transformed 
for presentation and plotted against A260/A280 ratio by collection method. To separate 
outliers (defined in the Results section) from the main cluster, four reference lines were 
applied. Vertical lines indicate A260/A280 ratios of 1.5 and 2.1. Horizontal lines indicate in 
DNA yields of 0.5 and 5. 
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Table 1. Summary of previous studies using saliva collection methods.	  	  
Year Population / Collection 
methods 
Conclusions Reference 
2001 cytobrush: n=120, 
mouthwash: n=40, 
Both methods are adequate for a wide 
range of PCR-based analysis. 
A single mouthwash sample provides 
larger amount and higher molecular weight 
DNA than two cytobrush samples. 
(14) 
2001 35 subjects-24 individuals 
(six men and 18 women) 
completed the study, 
Buccal cell, mouthwash 
Buccal samples should be collected before 
brushing teeth and processed within 5 days 
of collection to maximize DNA yield. 
(15) 
2002 24 participants (45 years 
or older) – 22 completed 
the study (9 men and 13 
women) 
Cytobrush is cost effective in large scale 
studies, and yields sufficient quantity and 
quality of DNA for genotyping. 
(16) 
2006 Buccal cell, mouthwash 
611 men 53-87 years 
Self-administered Oragene 
method 
Oragene saliva DNA is of high quality and 
can be used as alternative to blood. 
(2) 
2006 10 subjects Saliva is a viable alternative source of 
human genomic DNA for genetic 
epidemiological studies. 
(4) 
2006 5 males and 5 females 
Mouthwash and cheek 
cells using swabs. 
Saliva samples provide a substantial 
increase in the amount of human DNA. 
Saliva samples can be obtained and 
transported under field conditions without 
refrigeration. 
(19) 
2007 300 nurses, 51-91 years, 
Oragene® DNA self-
collection kit, Catch-All 
swabs, blood sample 
Saliva sampling is a good alternative to 
blood sampling and would increase the 
response rate considerably in 
epidemiologic studies. 
(20) 
2007 17 adult volunteers: 
Oragene® DNA collection 
kit, cytobrush, foam 
swabs, oral rinse. 
Both oral-rinse sample and whole-saliva 
sample provide sufficient DNA quantity 
and better quality DNA for genetic 
epidemiological studies than buccal swab 
and brush techniques. 
(21) 
2009 34 individuals: Buccal 
swabs and 1140 subjects: 
Catch-All swabs, Isohelix 
buccal 
The buccal swabs are convenient and cost 
effective alternative to blood sampling. 
They provide DNA of sufficient quantity 
and quality for high-throughput SNP 
multiplex analysis. 
(5) 
2009 565  individuals, 
Oragene® Self Collection 
Kits 
Demographic and behavioural 
characteristics of smoking cessation trial 
participants are associated with saliva and 
DNA metrics but not with the performance 
on genotyping. 
(1) 
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Table 2. Children fulfilling the inclusion criteria and providing saliva samples 
   Country         n % of total 
subjectsa 
   Age 
Mean (SD) 
    boys 
    % (N) 
   Italy 1952 86.8 6.1 (1.8)    51.6 (1007) 
  Estonia 1418 82.5 6.0 (2.0)    49.3 (699) 
  Cyprus 1679 70.5 6.1 (1.4)    51.3 (862) 
  Belgium 1524 79.1 5.7 (1.6)    51.0 (777) 
  Sweden 1601 88.5 5.9 (2.0)    51.2 (820) 
  Germany 1947 94.2 6.2 (1.8)    51.2 (997) 
  Hungary 2518 98.1 6.3 (1.8)    50.0 (1260) 
  Spain 1380 91.6 5.9 (1.7)    51.1 (705) 
  All        14019 86.4 6.1 (1.8)    50.8 (7127) 
	  
a	  proportion	  of	  subjects	  from	  each	  country	  (and	  the	  full	  cohort)	  that	  fulfilled	  the	  inclusion	  
criteria	  who	  also	  gave	  saliva	  samples	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Table 3. Comparison of DNA yield and quality by method of collection.  
  DNA yield (µg) A260/A280 ratio 
Collection Method n Mean SD Median (IQ) Mean SD Median (IQ) 
Total sample 4584 14.36 2.83 13.88 (7.35-27.26) 1.78 0.27 
1.80 
(1.67-1.91) 
Whole saliva 1962 20.95 2.35 21.76 (11.93-38.21) 1.77 0.18 
1.79 
(1.67-1.89) 
Sponge 2108 9.13 2.25 9.24 (5.23-15.90) 1.80 0.20 
1.82 
(1.69-1.93) 
	  
IQ:  Limits of the interquartile range   
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Table 4. Genotyping success rates in saliva samples. 
Gene ADRB2 ACE 
SNP 
rs
10
42
71
3 
rs
10
42
71
4 
rs
43
51
 
rs
43
62
 
rs
43
29
 
rs
42
95
 
rs
43
53
 
rs
43
11
 
% 
successful 
genotype 
calls 
96 96 96 97 97 96 96 97 
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Table 5. Genotyping success rate for the outliers. 
Number of SNP assays in which each sample resulted 
in successful genotype calls  
 
8 7 6 0-5 
Number (%) of outliers 
(total n=427) 
355 (83.1) 38 (8.9) 11 (2.6) 23 (5.4) 
% of non-outlier samples 
(total n=3,643) 89.8 7.4 1.5 1.3 
 
The table shows the number and percentage of samples giving successful genotype calls for 
the indicated number of SNP assays, i.e. 355 outlier samples were called in all 8 assays, 
whereas 23 outlier samples were successful in five assays or fewer. Percentage of non-outliers 
giving successful genotype calls are also given for comparison. 
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Figure 1. The relationship between DNA yield and quality from whole saliva and 
sponge samples	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